← Back to Search
Improving Motor Skill Development in Infants After Cardiac Surgery (DAISY Trial)
Ann Arbor, MI
N/A
Waitlist Available
Led By Karen Uzark, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after hospital discharge
Awards & highlights
No Placebo-Only Group
Summary
The purpose of this study is to learn more about developmental behaviors and to examine changes in developmental progress related to motor activities among a group of infants who received open heart surgery within the first three months of life.
See full description
Eligible Conditions
- Congenital Heart Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months after hospital discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after hospital discharge
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Gross Motor Scale score
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: inpatient/outpatientExperimental Treatment2 Interventions
Inpatient and outpatient recommendations to parents regarding infant motor activities
Group II: inpatientExperimental Treatment2 Interventions
Inpatient recommendations to parents regarding infant motor activities
Group III: standard careActive Control1 Intervention
Standard care comparison
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard care
2007
Completed Phase 4
~9600
Developmental recommendations
2016
N/A
~70
Find a Location
Closest Location:University of Michigan· Ann Arbor, MI
Who is running the clinical trial?
University of MichiganLead Sponsor
1,887 Previous Clinical Trials
6,462,298 Total Patients Enrolled
Karen Uzark, PhDPrincipal InvestigatorUniversity of Michigan